Discontinuing Escitalopram and Alternative Treatment Strategies

Mechanism of Action and Alternative Treatments

SNRIs like venlafaxine are mechanistically similar to SSRIs, enhancing serotonergic neurotransmission, which may perpetuate the same adverse reaction profile that caused problems with escitalopram, according to the American College of Physicians 1
The American College of Physicians found no superiority when switching between different serotonergic antidepressants, suggesting that staying within the same mechanistic class offers no clear advantage 1
Bupropion is the preferred alternative as it works through dopamine and norepinephrine mechanisms without significant serotonergic activity, avoiding the pathway that caused the adverse reaction 1, 2

Moderate-quality evidence from the STAR*D trial showed equivalent efficacy when switching to bupropion compared to other antidepressants, with significantly fewer discontinuations due to adverse events (12.5%) 1, 2
Bupropion augmentation demonstrated better tolerability than buspirone augmentation (12.5% vs. 20.6% discontinuation due to adverse events; P < 0.001) 2, 3
Consider switching to cognitive behavioral therapy (CBT) alone or in combination with a non-serotonergic agent, as low-quality evidence showed no difference in response or remission when switching to CBT versus switching to another antidepressant 1

The most critical monitoring period is the first 24-48 hours after any medication change, particularly when transitioning between serotonergic agents 4
Assess for signs of serotonin syndrome if any overlap occurs between discontinuing escitalopram and starting a new agent: mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity 3, 4